Trial intelligence / Profile preview

TNF-alpha blockade and atherothrombosis markers in rheumatoid arthritis

NL-OMON29079Active, not recruiting

Sponsor
Amsterdam University Medical Center
Start
Jan 2006
Countries
1
01

Overview

Open-label, single-arm trial in rheumatoid arthritis (RA), sponsored by Amsterdam University Medical Center. Primary endpoints: Endothelial function and Glycocalyx. Started Jan 2006; status: active, not recruiting.

02

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NL-OMON29079.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON29079.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call